Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Comparison of therapeutic response using RECIST criteria: Y-90 SIR-Spheres and TheraSphere treatment of unresectable hepatocellular carcinoma

Zhuangyu Zhang, M. Reza Fardanesh, Josef Machac, Sherif Heiba, Karin Knesaurek, Viktor Zaretsky, Adrian Mihaila, Scott Nowakowski, Aaron Fischman and Edward Kim
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 224;
Zhuangyu Zhang
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Reza Fardanesh
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef Machac
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherif Heiba
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Knesaurek
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viktor Zaretsky
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Mihaila
1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Nowakowski
2Radiology, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Fischman
2Radiology, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Kim
2Radiology, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 224

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Zhuangyu Zhang1,
  2. M. Reza Fardanesh1,
  3. Josef Machac1,
  4. Sherif Heiba1,
  5. Karin Knesaurek1,
  6. Viktor Zaretsky1,
  7. Adrian Mihaila1,
  8. Scott Nowakowski2,
  9. Aaron Fischman2 and
  10. Edward Kim2
  1. 1Nuclear Medicine, Mount Sinai School of Medicine, New York, NY
  2. 2Radiology, Mount Sinai School of Medicine, New York, NY

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014200
Feb 2015800
Mar 20151100
May 2015500
Jun 2015100
Jul 2015100
Aug 20151400
Sep 2015600
Oct 2015200
Nov 2015300
Dec 2015200
Jan 2016300
Feb 2016100
Mar 2016600
Apr 2016500
May 2016500
Jun 20162600
Jul 2016100
Aug 20161200
Sep 20161400
Oct 2016200
Nov 2016400
Dec 2016600
Jan 20172800
Feb 2017800
Mar 20172100
Apr 20171200
May 2017600
Jun 20171000
Jul 20171700
Aug 20172600
Sep 20171600
Oct 20172300
Nov 20172600
Dec 20171000
Jan 20181500
Feb 20181300
Mar 2018300
Apr 20181500
May 20181200
Jun 2018300
Jul 2018100
Aug 2018100
Sep 20182200
Oct 20181700
Nov 20182600
Dec 2018900
Jan 2019600
Feb 20191100
Mar 20192300
Apr 20193000
May 20191900
Jun 20192200
Jul 20191700
Aug 20192500
Sep 20191900
Oct 20191700
Nov 20192200
Dec 20192000
Jan 20201200
Feb 20202400
Mar 20201800
Apr 20202200
May 20201900
Jun 20201400
Jul 2020300
Aug 20201100
Sep 20201000
Oct 2020900
Nov 20201800
Dec 20201200
Jan 20213000
Feb 20212900
Mar 20213700
Apr 20212800
May 20212800
Jun 20212900
Jul 20213900
Aug 20214800
Sep 20214100
Oct 20213200
Nov 20212400
Dec 20212000
Jan 20222100
Feb 20224700
Mar 20224300
Apr 20223600
May 20221800
Jun 20222200
Jul 20224200
Aug 20223800
Sep 20224600
Oct 20225200
Nov 20223300
Dec 20223000
Jan 20233200
Feb 20232800
Mar 20232600
Apr 20233800
May 20235400
Jun 20235100
Jul 20233900
Aug 20235000
Sep 20234100
Oct 20233000
Nov 20233200
Dec 20233700
Jan 20244800
Feb 20242100
Mar 20243100
Apr 20241600
May 20243300
Jun 20242000
Jul 20247500
Aug 20245600
Sep 20243400
Oct 20242200
Nov 20242600
Dec 20242400
Jan 20252900
Feb 20252600
Mar 20252700
Apr 20253800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of therapeutic response using RECIST criteria: Y-90 SIR-Spheres and TheraSphere treatment of unresectable hepatocellular carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of therapeutic response using RECIST criteria: Y-90 SIR-Spheres and TheraSphere treatment of unresectable hepatocellular carcinoma
Zhuangyu Zhang, M. Reza Fardanesh, Josef Machac, Sherif Heiba, Karin Knesaurek, Viktor Zaretsky, Adrian Mihaila, Scott Nowakowski, Aaron Fischman, Edward Kim
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 224;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of therapeutic response using RECIST criteria: Y-90 SIR-Spheres and TheraSphere treatment of unresectable hepatocellular carcinoma
Zhuangyu Zhang, M. Reza Fardanesh, Josef Machac, Sherif Heiba, Karin Knesaurek, Viktor Zaretsky, Adrian Mihaila, Scott Nowakowski, Aaron Fischman, Edward Kim
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 224;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Optimizing PET/MRI Y-90 post-therapy imaging using PET/CT as a standard
  • Association between iodine intake and treatment outcomes dioiodine remnant ablation in patients with papillary thyroid cancer
  • Clinical implication of preablation thyroglobulin level in differentiated thyroid carcinoma patients underwent recombinant human thyrotropin aided ablative radioiodine treatment
Show more Oncology: Basic, Translational & Therapy

Radiopharmaceutical Therapy: SIRT, Miscellaneous

  • Therapeutic efficacy, safety and toxicity profile of 177Lu-EDTMP for bone pain palliation in metastatic prostate cancer: Initial results from a randomized clinical trial
  • Yttrium-90 PET/CT for the assessment of post-treatment microspheres biodistribution
  • SIRT is safe in the remnant liver post partial liver resection
Show more Radiopharmaceutical Therapy: SIRT, Miscellaneous

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire